Systemic lupus erythematosus trials recruiting in North Carolina

All Systemic lupus erythematosus trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
  NCT07570862 · Phase: Phase 2 · Ages: 12 Years to 70 Years · Sex: All (male and female) · North Carolina: Fayetteville
• A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
  NCT06411249 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Charlotte, Winston-Salem
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
  NCT06617325 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · North Carolina: Charlotte
• A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
  NCT06916806 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
  NCT07409181 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · North Carolina: Charlotte, Fayetteville
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · North Carolina: Durham
• Anifrolumab Pregnancy Study
  NCT07049653 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: Female · North Carolina: Cary
• Duke Lupus Registry
  NCT00512694 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Durham
• Intervention to Improve Communication and Medication Adherence in Lupus
  NCT06458075 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · North Carolina: Durham
• Maternal Autoimmune Disease Research Alliance (MADRA) Registry
  NCT03276923 · Phase: Not specified · Ages: No age limits stated · Sex: Female · North Carolina: Durham
• Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
  NCT06659029 · Phase: Not specified · Ages: No age limits stated · Sex: Female · North Carolina: Wilmington
• RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
  NCT06121297 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · North Carolina: Chapel Hill